Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Sex-specific impact of the manipulation of methionine cycle on T cell activation and gut microbiome in neuroinflammation

EF 2020-21

Résumé
Multiple sclerosis (MS) is an autoimmune disease characterized by lesions in the brain and spinal cord in a context of aberrant activation of immune cells, especially pro-inflammatory T cells. Women are 3 times more affected by MS than men. The etiology of MS is unknown, but factors like obesity, diet and modification of the gut microbiota are associated with its clinical course. A commonly used model to understand immune mechanism in MS is the experimental autoimmune encephalomyelitis (EAE) in mice. Methionine is an amino acid that needs to be provided by food. In its cycle, methionine is converted by the enzyme Mat2a in S-adenosylmethionine (SAM), which is able to influence expression of genes. Our collaborator Dr Jones has shown that reducing methionine or inhibiting Mat2a decreases the proliferation of pro-inflammatory T cells. Our team showed that dietary methionine restriction (MR) is associated with a delay in apparition of neurologic symptoms and reduce activation and infiltration in the brain and spinal cord of these inflammatory immune cells in EAE, the mouse model of MS. Our preliminary results suggest that MR ameliorates EAE in both males and females but that the impacts are not identical. Our hypothesis is that the reduction of methionine improves inflammatory mechanisms in EAE by modifying the generation of pro-inflammatory immune cells and the composition of the gut microbiota in a sex-specific manner. With a transgenic mouse model, we also propose to study the inhibition of Mat2a and its impact on the T cells and the gut microbiota in EAE according to biological sex. The goal of this project is to understand the mechanisms through which MR delays and reduces neurological symptoms in EAE to open new tailored therapeutics avenues for women and men with MS.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449594
Name
Millette Florence
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex-specific impact of the manipulation of methionine cycle on T cell activation and gut microbiome in neuroinflammation
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Confocal Microscopy; Experimental Autoimmune Encephalomyelitis; Flow Cytometry; Gut Microbiome; Methionine Metabolism; Multiple Sclerosis; Neuroimmunology; Neuroinflammation; Sexual Dimorphism; T Lymphocytes Metabolism
Abstract
Multiple sclerosis (MS) is an autoimmune disease characterized by lesions in the brain and spinal cord in a context of aberrant activation of immune cells, especially pro-inflammatory T cells. Women are 3 times more affected by MS than men. The etiology of MS is unknown, but factors like obesity, diet and modification of the gut microbiota are associated with its clinical course. A commonly used model to understand immune mechanism in MS is the experimental autoimmune encephalomyelitis (EAE) in mice. Methionine is an amino acid that needs to be provided by food. In its cycle, methionine is converted by the enzyme Mat2a in S-adenosylmethionine (SAM), which is able to influence expression of genes. Our collaborator Dr Jones has shown that reducing methionine or inhibiting Mat2a decreases the proliferation of pro-inflammatory T cells. Our team showed that dietary methionine restriction (MR) is associated with a delay in apparition of neurologic symptoms and reduce activation and infiltration in the brain and spinal cord of these inflammatory immune cells in EAE, the mouse model of MS. Our preliminary results suggest that MR ameliorates EAE in both males and females but that the impacts are not identical. Our hypothesis is that the reduction of methionine improves inflammatory mechanisms in EAE by modifying the generation of pro-inflammatory immune cells and the composition of the gut microbiota in a sex-specific manner. With a transgenic mouse model, we also propose to study the inhibition of Mat2a and its impact on the T cells and the gut microbiota in EAE according to biological sex. The goal of this project is to understand the mechanisms through which MR delays and reduces neurological symptoms in EAE to open new tailored therapeutics avenues for women and men with MS.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Millette, Florence
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~